← Back to Clinical Trials
Recruiting NCT01937949

NCT01937949 Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT01937949
Status Recruiting
Phase
Sponsor Gustavo S Oderich
Condition Juxtarenal Aortic Aneurysms
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2013-08
Primary Completion 2025-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Custom-made Zenith® Fenestrated AAA Endovascular Graft:

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2013-08 with a primary completion date of 2025-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to evaluate clinical outcomes and quality of life measures in treated by endovascular aortic repair of juxtarenal, suprarenal, and type IV thoracoabdominal aortic aneurysms using custom-made Cook Zenith® Fenestrated AAA Endovascular Graft.

Eligibility Criteria

General Inclusion Criteria * A patient may be included in the study if the patient has at least one of the following and is appropriate for treatment with a custom-made Zenith® Fenestrated AAA Endovascular Graft: * Juxtarenal, suprarenal or type IV thoracoabdominal aortic aneurysm with a diameter ≥ 5.0 cm or 2 times the normal aortic diameter * Aneurysm with a history of growth ≥ 0.5 cm per year * Saccular aneurysms deemed at significant risk for rupture based upon physician interpretation. General Exclusion Criteria * Less than 18 years of age * Unwilling to comply with the follow-up schedule * Inability or refusal to give informed consent by the patient or a legally authorized representative * Pregnant or breastfeeding * Life expectancy \< 2-years * Additional medical restrictions as specified in the Clinical Investigation Plan * Additional anatomical restrictions as specified in the Clinical Investigation Plan

Contact & Investigator

Central Contact

Andrea C Martinez, MS

✉ andrea.martinez@bcm.edu

📞 713-798-6835

Principal Investigator

Gustavo S. Oderich, MD

PRINCIPAL INVESTIGATOR

Baylor College of Medicine

Frequently Asked Questions

Who can join the NCT01937949 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Juxtarenal Aortic Aneurysms. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT01937949 currently recruiting?

Yes, NCT01937949 is actively recruiting participants. Contact the research team at andrea.martinez@bcm.edu for enrollment information.

Where is the NCT01937949 trial being conducted?

This trial is being conducted at Rochester, United States, Houston, United States.

Who is sponsoring the NCT01937949 clinical trial?

NCT01937949 is sponsored by Gustavo S Oderich. The principal investigator is Gustavo S. Oderich, MD at Baylor College of Medicine. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology